Researchers have been excited about the medication , a groundbreaking dual agonist showing significant data in initial trials for size reduction . It works by targeting both hormones : GLP-1 and GIP, https://nicoledops742702.blogzag.com/84160070/this-new-possibility-for-weight-loss